# Kehuizhiyao

Kehui Zhiyao develops innovative AI-driven drugs. Using its AI-driven drug development platform, it focuses on treatments for neurodegenerative diseases, cancer, and autoimmune diseases. Its core business is building an AI-driven drug discovery platform and using it to develop a range of small-molecule targeted drugs with proprietary intellectual property.

Kehui Zhiyao develops innovative AI-driven drugs. Using its AI-driven drug development platform, it focuses on treatments for neurodegenerative diseases, cancer, and autoimmune diseases. Its core business is building an AI-driven drug discovery platform and using it to develop a range of small-molecule targeted drugs with proprietary intellectual property.

Canonical: https://uniquebase.ai/products/kehuizhiyao
Stable identifier: UB-D354
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T22:20:32.065Z

## Connected profiles

- [Artivila](/companies/kehuizhiyao)

## Sources

- No source links are available for this profile.